BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Gangliosidoses

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Gangliosidoses:

Pubmed Logo
Juvenile-onset G(M2)-gangliosidosis in an African-American child with nystagmus.
G(M2)-gangliosidosis is a neurodegenerative lysosomal disease with several...
11th July, 2008
Division of Human Genetics, Department of Genetics and Developmental Pediatr Neurol. 2008 Apr;38(4):284-6.
DOI Direct Link
Hexosaminidase assays.
beta-Hexosaminidases (EC 3.2.1.52) are lysosomal enzymes that remove...
14th May, 2008
LIMES, Membrane Biology and Lipid Biochemistry Unit, c/o Kekule-Institut Glycoconj J. 2008 May 13;.
DOI Direct Link
Increased hexosaminidase activity in antipsychotic-induced extrapyramidal side effects: Possible association with higher occurrence in bipolar disorder patients.
Dystonic movements and Parkinsonism are frequently seen in gangliosidoses...
26th April, 2008
Dokuz Eylul University, Medical School, Izmir, Turkey. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1214-20. Epub
DOI Direct Link
An exposed carboxyl group on sialic acid is essential for gangliosides to inhibit calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase: relevance to gangliosidoses.
We previously observed that gangliosides GM2, GM1, and GM3 inhibit...
19th February, 2008
Department of Biological Chemistry, Weizmann Institute of Science, J Neurochem. 2008 Jan;104(1):140-6.
DOI Direct Link
[Neurological presentations of lysosomal diseases in adult patients]
Lysosomal diseases represent a large group of genetic storage disorders...
17th January, 2008
Federation des maladies du systeme nerveux et centre de reference national Rev Neurol (Paris). 2007 Oct;163(10):919-29.
DOI Direct Link

View more research publications.

Gangliosidoses Clinical Trials:

Clinical Trials Logo
Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis
Gangliosidoses GM2

Gangliosidoses Patents:

USPTO Logo
US Patent No.Title
6566099 Nucleic acid encoding a chimeric polypeptide
6919433 Antibodies to protein HPMBQ91
6926898 Albumin fusion proteins
6936688 Human chemokine beta-10 mutant polypeptides
6936691 Secreted protein HCE3C63

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Gangliosidoses scientists - we have details of around 70 individuals working on Gangliosidoses .


This page has been viewed 109 times
Recent Search Terms used to find this page: .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Gangliosidoses across BioPortfolio, or bestselling Gangliosidoses books or recently published Gangliosidoses books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional